p53-Mediated Tumor Suppression: DNA-Damage Response and Alternative Mechanisms
- PMID: 31835405
- PMCID: PMC6966539
- DOI: 10.3390/cancers11121983
p53-Mediated Tumor Suppression: DNA-Damage Response and Alternative Mechanisms
Abstract
The tumor suppressor p53 regulates different cellular pathways involved in cell survival, DNA repair, apoptosis, and senescence. However, according to an increasing number of studies, the p53-mediated canonical DNA damage response is dispensable for tumor suppression. p53 is involved in mechanisms regulating many other cellular processes, including metabolism, autophagy, and cell migration and invasion, and these pathways might crucially contribute to its tumor suppressor function. In this review we summarize the canonical and non-canonical functions of p53 in an attempt to provide an overview of the potentially crucial aspects related to its tumor suppressor activity.
Keywords: cancer; cell death; epigenetics; metabolism.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Understanding the non-canonical pathways involved in p53-mediated tumor suppression.Carcinogenesis. 2014 Apr;35(4):740-6. doi: 10.1093/carcin/bgt487. Epub 2013 Dec 31. Carcinogenesis. 2014. PMID: 24381013 Free PMC article.
-
Deciphering p53 signaling in tumor suppression.Curr Opin Cell Biol. 2018 Apr;51:65-72. doi: 10.1016/j.ceb.2017.11.005. Epub 2017 Nov 28. Curr Opin Cell Biol. 2018. PMID: 29195118 Free PMC article. Review.
-
Ferroptosis and the bidirectional regulatory factor p53.Cell Death Discov. 2023 Jun 29;9(1):197. doi: 10.1038/s41420-023-01517-8. Cell Death Discov. 2023. PMID: 37386007 Free PMC article. Review.
-
Unravelling mechanisms of p53-mediated tumour suppression.Nat Rev Cancer. 2014 May;14(5):359-70. doi: 10.1038/nrc3711. Epub 2014 Apr 17. Nat Rev Cancer. 2014. PMID: 24739573 Free PMC article.
-
Balancing and Differentiating p53 Activities toward Longevity and No Cancer?Cancer Res. 2020 Dec 1;80(23):5164-5165. doi: 10.1158/0008-5472.CAN-20-3080. Cancer Res. 2020. PMID: 33268555
Cited by
-
Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51.Nat Commun. 2023 Nov 16;14(1):7430. doi: 10.1038/s41467-023-42850-x. Nat Commun. 2023. PMID: 37973845 Free PMC article.
-
Programmed Cell Death Pathways in Cholangiocarcinoma: Opportunities for Targeted Therapy.Cancers (Basel). 2023 Jul 15;15(14):3638. doi: 10.3390/cancers15143638. Cancers (Basel). 2023. PMID: 37509299 Free PMC article. Review.
-
Metabolism-Guided Optimization of Tryptophanol-Derived Isoindolinone p53 Activators.Pharmaceuticals (Basel). 2023 Jan 19;16(2):146. doi: 10.3390/ph16020146. Pharmaceuticals (Basel). 2023. PMID: 37259297 Free PMC article.
-
Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma.Biomedicines. 2022 Dec 9;10(12):3202. doi: 10.3390/biomedicines10123202. Biomedicines. 2022. PMID: 36551958 Free PMC article. Review.
-
Targeting redox regulation and autophagy systems in cancer stem cells.Clin Exp Med. 2023 Sep;23(5):1405-1423. doi: 10.1007/s10238-022-00955-5. Epub 2022 Dec 6. Clin Exp Med. 2023. PMID: 36473988 Review.
References
-
- Amelio I., Mancini M., Petrova V., Cairns R.A., Vikhreva P., Nicolai S., Marini A., Antonov A.A., Le Quesne J., Baena Acevedo J.D., et al. p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression. Proc. Natl. Acad. Sci. USA. 2018;115:E10869–E10878. doi: 10.1073/pnas.1808314115. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
